Wegovy Weight Loss Pill Approved for Use in Australia
Published
The Therapeutic Goods Administration (TGA) has approved Wegovy, a weight loss medicine, to be sold in pill form across Australia. The decision means that eligible patients will soon be able to take the drug as a tablet instead of an injection.
Wegovy is a medicine that contains semaglutide. Until now, it has mainly been given as a weekly injection to adults who need help to manage their weight. The TGA is the government body that checks whether medicines are safe and effective before they can be sold in Australia, so its approval is an important step for the product.
Only patients who meet the eligibility rules will be able to access the new tablet. Doctors will still need to assess each patient and decide whether the treatment is suitable for them. The medicine is also expected to be used alongside healthy eating and regular physical activity, not as a replacement for them.
The approval may make weight loss treatment easier for some Australians who do not want to use injections. More details about when the pill will be available in pharmacies, and how much it will cost, are expected in the coming weeks.
Sources: News.com.au
More Australia news
- Trellis Data unveils Agentaus 1 AI model in Australia
- Australia set to run out of Q fever vaccine this week
- Missing 17-year-old William found alive in Victoria bushland
- Australia to Create New AI Safety Regulator After OpenAI Incident
- Australia Moves to Tighten AI Safety Laws After Review of OpenAI Incident
- Qantas to Cut Nearly 1,000 Jobs as It Points to Artificial Intelligence
- Australia to Introduce Mandatory AI Reporting After OpenAI Hack
- Australia Plans New AI Safety Standards and a Watchdog to Enforce Them